Kim Milliken

Kim Milliken is the current Senior Director of Regulatory CMC at Verve Therapeutics. Kim has over 25 years of experience in the field of Regulatory Affairs and Quality Control.

Kim started their career in 1991 as a Microbiology Planter at Path Lab. Kim then moved to Biogen in 1993 as a QC Analyst. In 1995, they became QC Microbiology Manager at Lonza Biologics, Inc., and in 2003 they became Head of QC at Lonza AG in Visp, Switzerland. Kim returned to Lonza Biologics in 2005 as Director of Regulatory Affairs and held that position until 2016 when they joined Takeda as Senior Director Regulatory, CMC. Kim has been with Verve Therapeutics since October 2016.

Kim Milliken reports to Kallanthottathil G. Rajeev, VP, CMC. Some of their coworkers include Jennifer Lavoie - Director, CMC Project Management.